AcelRx Pharmaceuticals

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -66.09% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -63.04% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -62.61% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -6.96% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -4.35% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -9.57% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -11.30% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -12.17% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -9.13% away from its yearly high level, during the last trading session. The

AcelRx Pharmaceuticals, Inc., (NASDAQ: ACRX) was trading -1.79% away from its yearly high level, during the last trading session. The